ClearPoint Neuro Inc. - Common Stock (CLPT)

CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate.

These top growth stocks across various sectors have the potential to deliver 5X returns in just five years.

CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

These penny stocks offer robust operational opportunities amid wider economic and market concerns pushing weaker companies downward.

MedTech stocks are often overlooked despite the inherent healthcare growth trajectory and industry-wide innovative spirit.

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

These under-$15 stocks to buy are one of the few deals remaining in today's economic environment. Don't miss out.

These small-cap tech stocks are well on their way to a meteoric and historic rise, but it isn't too late to jump on the bandwagon.

Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.

Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.

Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.

Small-cap stocks are massively undervalued and represent a unique investment opportunity for traders in 2024.

Small-cap stocks are positioned to beat the biggest companies in 2024 as risk tolerance climbs and shares remain undervalued